bpc-157 fda approval status 2024 The Food and Drug Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make. Follow the link FDA's Overreach on Compounded Peptides
FDA's Overreach on Compounded Peptides FDA is reviewing seven peptides this week, BPC 157, MOTS c, and Epitalon among them. Committee meets Thursday and Friday, and the likely outcome is tighter restrictions on compounding pharmacies. Read past the headline Want the FDA to Make Peptides Safer? 83% of You Said Yes FDA panel backs compounded BPC 157, KPV peptides in win for RFK Jr. STAT Is BPC157 Legal? WADA, FDA Status, and What You Need to Know
Pay in 4 interest-free payments of $6.80 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6


